Quercetin-induced downregulation of phospholipase D1 inhibits proliferation and invasion in U87 glioma cells

Biochemical and Biophysical Research Communications

Volumn 412, Issue 4, 2011, Pages 710-715

  Park, Mi Hee ^a   Min, Do Sik ^a  

^a Pusan National University   (South Korea)

Author keywords

Invasion; NF B; Phospholipase D1; Proliferation; Quercetin

Indexed keywords

GELATINASE A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDIC ACID; PHOSPHOLIPASE D1; QUERCETIN;

ARTICLE; CANCER INHIBITION; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSACTIVATION;

BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GLIOMA; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; PHOSPHOLIPASE D; QUERCETIN;

EID: 80052608448     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.08.037     Document Type: Article

References (37)

1. Brit D.F., Hendrich S., Wang W. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol. Ther. 2001, 90:155-177.
2. Surh Y.J. Cancer chemoprevention with dietary phytochemicals. Nat. Rev. Cancer 2003, 3:768-780.
3. Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem. Pharmacol. 1983, 32:1141-1148.
4. Csokay B., Prajda N., Weber G., Olah E. Molecular mechanisms in the antiproliferative action of quercetin. Life Sci. 1997, 60:2157-2463.
5. Aghdassi A., Phillips P., Dudeja V., Dhaulakhandi D., Sharif R., Dawra R., Lerch M.M., Saluja A. Heat shock protein 7 increases tumorigenicity and inhibits apoptosis in pancreatic adenocarcinoma. Cancer Res. 2007, 67:616-625.
6. Min Y.D., Choi C.H., Bark H., Son H.Y., Park H.H., Lee S., Park J.W., Park E.K., Shin H.I., Kim S.H. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflamm. Res. 2007, 56:210-215.
7. Kim H., Kong H., Choi B., Yang Y., Kim Y., Lim M.J., Neckers L., Jung Y. Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease. Pharm. Res. 2005, 22:1499-1509.
8. Lefranc F., Brotchi J., Kiss R. Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J. Clin. Oncol. 2005, 23:2411-2422.
9. Demuth T., Berens M.E. Molecular mechanisms of glioma cell migration and invasion. J. Neurooncol. 2004, 70:217-228.
10. Forsyth P.A., Wong H., Laing T.D., Rewcastle N.B., Morris D.G., Muzik H., Leco K.J., Johnston R.N., Brasher P.M., Sutherland G., Edwards D.R. Gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br. J. Cancer 1999, 79:1828-1835.
11. Vijayababu M.R., Arunkumar A., Kanagaraj P., Venkataraman P., Krishnamoorthy G., Arunakaran J. Quercetin downregulates matrix metalloproteinases 2 and 9 proteins expression in prostate cancer cells (PC-3). Mol. Cell. Biochem. 2006, 287:109-116.
12. Lin C.W., Hou W.C., Shen S.C., Juan S.H., Ko C.H., Wang L.M., Chen Y.C. Quercetin inhibition of tumor invasion via suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9 activation in breast carcinoma cells. Carcinogenesis 2008, 29:1807-1815.
13. Chiu W.T., Shen S.C., Chow J.M., Lin C.W., Shia L.T., Chen Y.C. Contribution of reactive oxygen species to migration/invasion of human glioblastoma cells U87 via ERK-dependent COX-2/PGE(2) activation. Neurobiol. Dis. 2010, 37:118-129.
14. Foster D.A., Xu L. Phospholipase D in cell proliferation and cancer. Mol. Cancer Res. 2003, 1:789-800.
15. Hui L., Abbas T., Pielak R.M., Joseph T., Bargonetti J., Foster D.A. Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53. Mol. Cell. Biol. 2004, 24:5677-5686.
16. Kato Y., Lambert C.A., Colige A.C., Mineur P., Noël A., Frankenne F., Foidart J.M., Baba M., Hata R., Miyazaki K., Tsukuda M. Acidic extracellular pH induces matrix metalloproteinase-9 expression in mouse metastatic melanoma cells through the phospholipase D-mitogen-activated protein kinase signaling. J. Biol. Chem. 2005, 280:10938-10944.
17. Jenkins G.M., Frohman M.A. Phospholipase D: a lipid centric review. Cell. Mol. Life Sci. 2005, 62:2305-2316.
18. Kang D.W., Choi K.Y., Min D.S. Phospholipase D meets Wnt signaling: a new target for cancer therapy. Cancer Res. 2011, 71:293-297.
19. Min D.S., Kwon T.K., Park W.S., Chang J.S., Park S.K., Ahn B.H., Ryoo Z.Y., Lee Y.H., Lee Y.S., Rhie D.J., Yoon S.H., Hahn S.J., Kim M.S., Jo Y.H. Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts. Carcinogenesis 2001, 22:1641-1647.
20. Kang D.W., Min D.S. Platelet derived growth factor increases phospholipase D1 but not phospholipase D2 expression via NFkappaB signaling pathway and enhances invasion of breast cancer cells. Cancer Lett. 2010, 294:125-133.
21. Park M.H., Ahn B.H., Hong Y.K., Min D.S. Overexpression of phospholipase D enhances matrix metalloproteinase-2 expression and glioma cell invasion via protein kinase C and protein kinase A/NF-kappaB/Sp1-mediated signaling pathways. Carcinogenesis 2009, 30:356-365.
22. Kang D.W., Park M.H., Lee Y.J., Kim H.S., Kwon T.K., Park W.S., Min D.S. Phorbol Ester Up-regulates Phospholipase D1 but Not Phospholipase D2 Expression through a PKC/Ras/ERK/NF{kappa}B-dependent Pathway and Enhances Matrix Metalloproteinase-9 Secretion in Colon Cancer Cells. J. Biol. Chem. 2008, 283:4094-4104.
23. Ahn B.H., Min G., Bae Y.S., Bae Y.S., Min D.S. Phospholipase D is activated and phosphorylated by casein kinase-II in human U 87 astroglioma. Exp. Mol. Med. 2006, 38:55-62.
24. Knoepp S.M., Chahal M.S., Xie Y., Zhang Z., Brauner D.J., Hallman M.A., Robinson S.A., Han S., Imai M., Tomlinson S., Meier K.E. Effects of active and inactive phospholipase D2 on signal transduction, adhesion, migration, invasion, and metastasis in EL4 lymphoma cells. Mol. Pharmacol. 2008, 74:574-584.
25. Gupta S.C., Kim J.H., Prasad S., Aggarwal B.B. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metast. Rev. 2010, 29:405-434.
26. Lamson D.W., Brignall M.S. Antioxidants and cancer, part 3: quercetin. Altern. Med. Rev. 2000, 5:196-208.
27. Mouria M., Gukovskaya A.S., Jung Y., Buechler P., Hines O.J., Reber H.A., Pandol S.J. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome c release and apoptosis. Int. J. Cancer 2002, 98:761-769.
28. Nair H.K., Rao K.V., Aalinkeel R., Mahajan S., Chawda R., Schwartz S.A. Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin. Diagn. Lab. Immunol. 2004, 11:63-69.
29. Chowdhury S.A., Kishino K., Satoh R., Hashimoto K., Kikuchi H., Nishikawa H., Shirataki Y., Sakagami H. Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. Anticancer Res. 2005, 25:2055-2063.
30. Steed P.M., Chow A.H. Intracellular signaling by phospholipase D as a therapeutic target. Curr. Pharm. Biotechnol. 2001, 2:241-256.
31. Lampert K., Machein U., Machein M.R., Conca W., Peter H.H., Volk B. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Am. J. Pathol. 1998, 153:429-437.
32. Sawaya R.E., Yamamoto M., Gokaslan Z.L., Wang S.W., Mohanam S., Fuller G.N., McCutcheon I.E., Stetler-Stevenson W.G., Nicolson G.L., Rao J.S. Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin. Exp. Metast. 1996, 14:35-42.
33. Su W., Yeku O., Olepu S., Genna A., Park J.S., Ren H., Du G., Gelb M.H., Morris A.J., Frohman M.A. 5-Fluoro-2-indolyl des-chlorohalopemide (FIPI), a phospholipase D pharmacological inhibitor that alters cell spreading and inhibits chemotaxis. Mol. Pharmacol. 2009, 75:436-437.
34. Scott S.A., Selvy P.E., Buck J.R., Cho H.P., Criswell T.L., Thomas A.L., Armstrong M.D., Arteaga C.L., Lindsley C.W., Brown H.A. Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness. Nat. Chem. Biol. 2009, 5:108-117.
35. Kang D.W., Lee J.Y., Oh D.H., Park S.Y., Woo T.M., Kim M.K., Park M.H., Jang Y.H., Min D.S. Triptolide-induced suppression of phospholipase D expression inhibits proliferation of MDA-MB-231 breast cancer cells. Exp. Mol. Med. 2009, 41:678-685.
36. Kiviharju T.M., Lecane P.S., Sellers R.G., Peehl D.M. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin. Cancer Res. 2002, 8:2666-2674.
37. Kang D.W., Min G., Park Do Y., Hong K.W., Min D.S. Rebamipide-induced downregulation of phospholipase D inhibits inflammation and proliferation in gastric cancer cells. Exp. Mol. Med. 2010, 42:555-564.